查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012355

人工智慧在医疗诊断领域的市场：按组件、技术类型、部署模式、应用和最终用户划分－2026-2032年全球市场预测

Artificial Intelligence in Medical Diagnostics Market by Component, Technology Type, Deployment Mode, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗诊断领域的人工智慧 (AI) 市场价值将达到 19.1 亿美元，到 2026 年将成长到 21.9 亿美元，到 2032 年将达到 52.6 亿美元，复合年增长率为 15.57%。

主要市场统计数据
基准年 2025 19.1亿美元
预计年份：2026年 21.9亿美元
预测年份 2032 52.6亿美元
复合年增长率 (%) 15.57%

简要概述演算法进步、临床检验需求和系统互通性如何重新定义现代医学的诊断过程。

人工智慧正在重塑临床医生、实验室技术人员和医疗管理人员的诊断方式，在演算法洞察和临床工作流程之间建立新的联繫。近年来，模型架构的改进、更丰富的临床资料集的取得以及影像技术的成熟，共同提升了人工智慧驱动工具在诊断过程中的实用性。因此，医疗机构正优先投资于将预测分析和影像技术整合到标准诊疗流程中的整合解决方案，以减少诊断延误并提高诊断结果的一致性。

深度学习、多模态临床数据和管治期望的融合如何改变诊断实​​践和筹资策略。

先进的机器学习技术、更丰富的多模态资料集以及对临床级性能日益增长的期望，正在改变医学诊断领域。深度学习和电脑视觉显着提升了成像能力，使得放射学、病理学和眼科学领域能够实现病灶的自动检测、分割和表征。同时，自然语言处理和资料探勘技术能够从非结构化的临床记录和实验室报告中提取有价值的信息，从而增强对诊断的上下文理解，并为决策提供支援。

本研究评估了美国近期关税措施如何推动诊断解决方案中的硬体采购变化、以软体为中心的调整以及供应链弹性策略。

美国近期宣布的关税调整和贸易措施，对人工智慧诊断系统的供应链产生了重大影响，带来了新的限制和奖励。作为高效能推理平台和影像处理工作站基础的硬体组件，例如记忆体和处理器，正面临日益增长的成本压力，因为关税推高了进口成本并限制了供应商的选择。因此，解决方案架构师和采购经理正在重新审视整体拥有成本 (TCO) 和筹资策略，并探索替代供应路线和本地生产方案以降低风险。

详细的细分洞察揭示了组件、技术、部署模型、临床应用和最终用户环境如何定义差异化的部署路径。

一套精细的细分框架清晰地展现了整个医疗诊断人工智慧生态系统的部署路径和产品优先顺序。逐一组件分析，硬体、服务和软体的需求各不相同。硬体需求专注于高吞吐量记忆体和处理器，以支援即时推理和进阶影像重建。另一方面，服务主要涵盖安装和整合工作流程，确保临床系统得到正确配置、检验并被医疗团队接受。软体产品范围广泛，包括辅助解读诊断结果的诊断软体、增强视觉化和工作流程的影像处理软体，以及整合纵向资料进行风险分层的预测分析软体。

一项区域比较分析，展示了法律规范、数位基础设施和组织优先事项如何影响世界各地市场的采用进展。

区域趋势正在影响人工智慧在医疗诊断领域的应用速度、监管预期和投资重点。在美洲，医疗保健系统和私人保险公司正在积极试点和推广人工智慧解决方案，尤其註重互通性、报销相容性以及与高通量成像工作流程的整合。大学附属医院和大规模医院网路通常扮演早期采用者和参考站点的角色，支援临床检验研究和上市后监测活动，指南更广泛的部署。

在诊断人工智慧生态系统中，竞争动态、伙伴关係和证据产生策略如何影响供应商差异化和部署结果？

从企业层面来看，一个由成熟技术供应商、专业医疗设备製造商和敏捷型Start-Ups组成的生态系统正在形成，它们彼此互补。市场领导者倾向于透过端到端解决方案图脱颖而出，这些解决方案融合了检验的演算法、强大的部署工具、面向临床医生的可解读功能以及整合和培训支援服务。同时，专业公司则专注于高价值的细分领域，例如用于肿瘤和病理诊断支援的高级影像处理演算法，并利用深厚的临床伙伴关係关係来加速检验和推广应用。

为医疗保健领导者制定可操作的策略重点，以在管理检验、管治和供应链风险的同时，实现人工智慧驱动的诊断。

产业领导者应采取协作方式，将技术潜力转化为可衡量的临床和营运成果。首先，他们应优先考虑稳健的临床检验流程，该流程应包含多学科团队，并在具有代表性的临床环境中进行前瞻性评估。这种方法有助于增强临床医生的信心，并支持合规性。其次，他们应采用模组化系统设计，以促进分阶段部署。这使得机构能够在不彻底改造基础设施的情况下整合特定的诊断软体和预测模组，从而减少营运中断并加速价值实现。

结论强调，循证实施、跨部门协作和强大的架构对于实现诊断人工智慧的益处至关重要。

总之，人工智慧在医疗诊断领域的应用正从孤儿的先导计画逐步发展为整合的临床工作流程，从而在影像、临床检验和病患监测等领域提供可操作的洞见。这项转变的驱动力在于模型表现的提升、临床医师对演算法辅助的接受度不断提高，以及对验证和管治的日益重视，以确保病人安全和公平的治疗结果。同时，政策变化和贸易趋势正在重塑供应链决策，引导相关人员转向以软体为先导的架构和多元化的筹资策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：人工智慧在医疗诊断领域的市场：按组件划分

  • 硬体
    • 记忆
    • 处理器
  • 服务
    • 实施与集成
  • 软体
    • 诊断软体
    • 影像处理软体
    • 预测分析软体

第九章：人工智慧在医疗诊断领域的市场：按技术类型划分

  • 电脑视觉
  • 资料探勘
  • 深度学习
  • 机器学习
  • 自然语言处理

第十章：人工智慧在医疗诊断领域的市场：以部署模式划分

  • 基于云端的
  • 现场

第十一章：人工智慧在医疗诊断领域的市场：按应用划分

  • 医学影像和诊断应用
    • 循环系统
    • 神经病学
    • 妇产科
    • 肿瘤学
    • 眼科
    • 放射科
  • 体外诊断应用
    • 伴随诊断
    • 免疫检测测定诊断
    • 分子诊断
  • 个人化医疗
  • 远端监测和远端保健

第十二章：人工智慧在医疗诊断领域的市场：按最终用户划分

  • 学术机构
  • 诊断中心
  • 医院
  • 研究所

第十三章：人工智慧在医疗诊断领域的市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：人工智慧在医疗诊断领域的市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：人工智慧在医疗诊断领域的市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医疗诊断领域的人工智慧市场

第十七章：中国医疗诊断领域的人工智慧市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • AiCure, LLC
  • Aidoc Medical Ltd.
  • Butterfly Network, Inc.
  • Cera Care Limited
  • Cisco Systems, Inc.
  • Corti-AI
  • Digital Diagnostics Inc.
  • Edifecs, Inc.
  • Enlitic, Inc.
  • Epredia by PHC Holdings Corporation
  • Freenome Holdings, Inc.
  • GE HealthCare Technologies, Inc.
  • General Vision, Inc.
  • Google LLC by Alphabet Inc.
  • Hewlett Packard Enterprise Development LP
  • Imagen Technologies, Inc.
  • Intel Corporation
  • International Business Machines Corporation
  • Johnson & Johnson Services, Inc.
  • Kantify
  • Koninklijke Philips NV
  • Medtronic PLC
  • Microsoft Corporation
  • Nano-X Imaging Ltd.
  • NEC Corporation
  • NVIDIA Corporation
  • Persistent Systems Limited
  • Qure.ai Technologies Private limited
  • Siemens Healthineers AG
  • SigTuple Technologies Private Limited
  • Stryker Corporation
  • Tempus Labs, Inc.
  • VUNO Inc.
Product Code: MRR-43492DACC312

The Artificial Intelligence in Medical Diagnostics Market was valued at USD 1.91 billion in 2025 and is projected to grow to USD 2.19 billion in 2026, with a CAGR of 15.57%, reaching USD 5.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.91 billion
Estimated Year [2026] USD 2.19 billion
Forecast Year [2032] USD 5.26 billion
CAGR (%) 15.57%

A concise orientation to how algorithmic advancement, clinical validation demands, and system interoperability are redefining diagnostic pathways in modern healthcare

Artificial intelligence is reshaping how clinicians, laboratory specialists, and healthcare administrators approach diagnostics, creating new intersections between algorithmic insight and clinical workflow. Over recent years, improvements in model architectures, access to richer clinical datasets, and maturation of imaging modalities have collectively raised the practical applicability of AI-driven tools in diagnostic pathways. Consequently, organizations are prioritizing investments in integrated solutions that embed predictive analytics and image interpretation into standard-of-care processes to reduce diagnostic delay and improve consistency of interpretation.

Moreover, regulatory agencies and clinical societies have increased guidance and scrutiny on algorithmic safety, explainability, and clinical validation, prompting development teams to align product development with evidentiary standards that mirror clinical trial rigor. This regulatory evolution, together with a growing emphasis on interoperability with electronic health records and laboratory information systems, is compelling vendors to adopt modular, standards-based architectures. In turn, payers and provider networks are experimenting with reimbursement frameworks and value-based arrangements that recognize the potential operational and clinical benefits of AI-enabled diagnostics.

As adoption expands across point-of-care, imaging centers, and centralized laboratories, stakeholders must balance rapid innovation with robust governance and risk management. Therefore, leaders should prioritize cross-functional collaboration among data scientists, clinicians, and regulatory experts to ensure that AI tools demonstrate transparent performance, equitable outcomes across diverse populations, and seamless integration into existing diagnostic pathways.

How the convergence of deep learning, multimodal clinical data, and governance expectations is reshaping diagnostic practice and procurement strategies

The landscape of medical diagnostics is undergoing transformative shifts driven by the convergence of advanced machine learning techniques, richer multimodal datasets, and heightened expectations for clinical-grade performance. Deep learning and computer vision have elevated the capabilities of image-based diagnostics, enabling automated detection, segmentation, and characterization of pathologies across radiology, pathology, and ophthalmology. At the same time, natural language processing and data-mining approaches are unlocking insights from unstructured clinical notes and laboratory reports, thereby enhancing diagnostic context and decision support.

Institutional priorities are shifting from siloed pilot projects to enterprise-level deployments that require robust change management and demonstrable clinical utility. This movement is accompanied by a growing emphasis on explainability and fairness, with algorithm developers embedding interpretability features and bias mitigation strategies to satisfy clinicians and regulators. Concurrently, deployment approaches are diversifying; organizations increasingly weigh cloud-based scalability against on-premise control to meet data residency, latency, and privacy requirements. These trends are catalyzing partnerships among technology vendors, healthcare systems, and academic centers to co-develop solutions that align with clinical workflows and compliance needs.

Finally, the integration of AI into diagnostics is creating new value propositions beyond single-test augmentation. Predictive analytics that combine imaging, genomic, and longitudinal clinical data are enabling earlier risk stratification and personalized care planning. As a result, stakeholders are re-evaluating procurement strategies, technical architectures, and governance frameworks to capture the benefits of algorithmic insight while managing operational complexity and ethical obligations.

Assessing how recent United States tariff measures are prompting hardware sourcing shifts, software-centric adaptations, and supply chain resilience strategies for diagnostic solutions

Recent tariff changes and trade measures announced by the United States have introduced a new set of constraints and incentives that meaningfully affect supply chains for AI-enabled diagnostic systems. Hardware components such as memory and processors, which underpin high-performance inference platforms and imaging workstations, face upward cost pressure when tariffs increase import costs and constrain supplier choices. As a consequence, solution architects and procurement leaders are rethinking total cost of ownership and sourcing strategies, seeking alternative supply routes or localized manufacturing to mitigate exposure.

In response to these policy shifts, some stakeholders are accelerating the transition toward software-centric and cloud-enabled models that reduce dependency on specialized on-premise servers, while simultaneously negotiating long-term procurement contracts to lock in component pricing. However, cloud strategies introduce their own considerations: data transfer costs, cross-border data governance, and potential latency constraints for real-time imaging workflows. Therefore, governance teams must recalibrate risk assessments to account for a changing balance between hardware acquisition and software subscription models.

Additionally, tariffs have encouraged investment in domestic capacity-building initiatives and strategic partnerships that aim to secure resilient supply lines for critical components. Regulatory and procurement teams are engaging with vendors to secure transparency around component provenance and to implement contingency planning that preserves clinical operations during supply disruptions. Ultimately, tariffs are catalyzing a broader re-evaluation of how diagnostic solutions are designed, procured, and deployed, favoring architectures that emphasize modularity, cloud interoperability, and flexible financing terms to accommodate evolving trade dynamics.

Detailed segmentation insights revealing how components, technologies, deployment modes, clinical applications, and end-user settings define differentiated adoption pathways

A nuanced segmentation framework illuminates distinct adoption pathways and product priorities across the AI in medical diagnostics ecosystem. When examined by component, demand differentiates between hardware, services, and software. Hardware requirements concentrate on high-throughput memory and processors that support real-time inference and advanced image reconstruction, while services primarily encompass installation and integration workstreams that ensure clinical systems are configured, validated, and accepted by care teams. Software offerings span diagnostic software that aids interpretation, imaging software that enhances visualization and workflow, and predictive analysis software that synthesizes longitudinal data for risk stratification.

By technology type, solutions vary from computer vision systems optimized for image analytics to data mining tools that surface latent patterns across clinical repositories. Deep learning models drive many high-performance image tasks, whereas machine learning techniques and natural language processing enable predictive modeling and unstructured data interpretation, respectively. Choice of deployment mode further differentiates offerings: cloud-based platforms offer scalability, continuous model updates, and centralized governance, while on-premise deployments provide localized control, lower latency for certain workflows, and alignment with strict data residency requirements.

Application-centric segmentation highlights divergent clinical use cases. Imaging and diagnostics applications span cardiology, neurology, obstetrics/gynecology, oncology, ophthalmology, and radiology, each demanding tailored validation datasets and clinician workflows. In-vitro diagnostics applications include companion diagnostics, immunoassay diagnostics, and molecular diagnostics, which integrate algorithmic interpretation with laboratory instrumentation and reporting systems. Personalized medicine workflows rely on predictive analysis to tailor therapeutic decisions, and remote monitoring and telehealth solutions leverage algorithms to triage care and monitor disease progression. Finally, end-user segmentation recognizes that adoption dynamics differ substantially across academic institutions, diagnostic centers, hospitals, and research laboratories, with each setting imposing unique procurement cycles, regulatory expectations, and integration challenges.

Comparative regional analysis showing how regulatory frameworks, digital infrastructure, and institutional priorities influence adoption trajectories across global markets

Regional dynamics shape the adoption velocity, regulatory expectations, and investment priorities for AI in medical diagnostics. In the Americas, health systems and private payers are actively piloting and scaling AI solutions, with a strong emphasis on interoperability, reimbursement alignment, and integration into high-throughput imaging workflows. Academic medical centers and large hospital networks often act as early adopters and reference sites, supporting clinical validation studies and post-market surveillance activities that inform broader rollouts.

Across Europe, the Middle East & Africa, regulatory harmonization and privacy frameworks lead decision-making, with providers emphasizing data protection, model explainability, and cross-border data transfer safeguards. Public-sector health systems and national procurement mechanisms influence the pace of adoption, and partnerships between regional OEMs and local integrators frequently determine rollout feasibility, particularly in contexts where digital infrastructure varies widely.

In the Asia-Pacific region, rapid digitization, large patient volumes, and strong public-private collaboration have accelerated development of AI-powered diagnostic workflows. Capacity-building initiatives and investments in domestic semiconductor and cloud capabilities are also influencing procurement decisions, while regional diversity in clinical practice necessitates careful localization of training datasets and clinical validation protocols. Across all regions, cross-border collaborations, regulatory consonance, and infrastructure investments remain key enablers for broad and equitable deployment of AI-enabled diagnostics.

How competitive dynamics, partnerships, and evidence generation strategies are shaping vendor differentiation and adoption outcomes in the diagnostic AI ecosystem

Key company-level dynamics demonstrate an ecosystem in which established technology providers, specialized medical device manufacturers, and agile startups all play complementary roles. Market leaders tend to differentiate through end-to-end offerings that combine validated algorithms with robust deployment tooling, clinician-facing interpretability features, and support services for integration and training. At the same time, specialist companies focus on high-value niches such as advanced imaging algorithms for oncology or diagnostic decision support for pathology, leveraging deep clinical partnerships to accelerate validation and uptake.

Strategic activity across the competitive landscape includes partnerships with academic centers to secure high-quality training datasets and clinical trial collaborators, alliances with cloud vendors to ensure scalable infrastructure, and collaborations with systems integrators to simplify deployment in complex health IT environments. Additionally, there is a pronounced emphasis on creating regulatory dossiers and post-market evidence collections that satisfy both clinical stakeholders and oversight bodies. Emerging entrants are concentrating on differentiating through explainability, bias mitigation, and workflow ergonomics, while incumbents are investing in modular architectures and APIs to maintain relevance.

Overall, the competitive environment favors organizations that can demonstrate clinical impact, provide transparent performance metrics, and streamline the pathway from pilot to enterprise deployment. Companies that excel at clinical validation, security, and seamless interoperability are best positioned to capture sustained adoption within complex healthcare ecosystems.

Actionable strategic priorities for healthcare leaders to operationalize AI-driven diagnostics while managing validation, governance, and supply chain risks

Industry leaders should take a coordinated approach to turn technological promise into measurable clinical and operational outcomes. First, prioritize robust clinical validation pathways that involve multidisciplinary teams and prospective evaluation in representative clinical environments; this approach builds clinician trust and supports regulatory compliance. Secondly, adopt modular system designs that facilitate incremental deployment, allowing organizations to integrate specific diagnostic software or predictive modules without full infrastructure overhaul, thereby reducing disruption and accelerating value realization.

Third, strengthen data governance practices by implementing provenance tracking, model versioning, and bias assessment protocols to ensure equitable performance across patient populations. In parallel, evaluate hybrid deployment architectures that balance cloud-based scalability with on-premise control for latency-sensitive workflows. Fourth, cultivate strategic supplier relationships and contingency plans to mitigate supply chain risk, particularly for critical hardware elements such as memory and processors; such measures should include diversification of suppliers and exploration of long-term procurement arrangements.

Finally, invest in clinician-centric design, training, and change management to ensure that AI tools augment clinical decision-making rather than introduce workflow friction. By aligning product development, procurement, and clinical operational teams early in the adoption lifecycle, organizations can accelerate implementation, demonstrate outcome improvements, and create defensible value propositions for payers and health system leaders.

This research synthesis relies on a multi-method approach that triangulates primary interviews, peer-reviewed literature, regulatory guidance, and technical whitepapers to develop a comprehensive view of AI in medical diagnostics. Primary qualitative inputs were gathered from clinicians, laboratory directors, health IT architects, and regulatory specialists to capture real-world implementation challenges and priorities. Technical assessments evaluated algorithmic approaches across computer vision, deep learning, machine learning, data mining, and natural language processing to understand strengths, limitations, and suitability for distinct clinical tasks.

Additionally, deployment mode analysis compared cloud-based and on-premise models with respect to scalability, latency, and data governance. Application-level insights drew on case studies across imaging and diagnostics, in-vitro diagnostics, personalized medicine, and remote monitoring scenarios to illustrate workflow integration and validation requirements. End-user perspectives were analyzed across academic institutions, diagnostic centers, hospitals, and research laboratories to highlight procurement cycles, technical readiness, and adoption barriers. Finally, supply chain and policy analyses examined the effects of tariff measures, component sourcing, and domestic manufacturing incentives on hardware availability and procurement strategies.

Throughout, findings emphasize reproducibility and transparency: methodology appendices document interview protocols, inclusion criteria for literature review, and technical evaluation frameworks, enabling readers to interpret the evidence base and adapt conclusions to their organizational context.

A concluding synthesis emphasizing the imperative for evidence-driven deployment, cross-functional collaboration, and resilient architectures to realize diagnostic AI benefits

In conclusion, integrating artificial intelligence into medical diagnostics is advancing from isolated pilots toward integrated clinical workflows that deliver actionable insights across imaging, laboratory, and patient-monitoring domains. The transition is driven by improvements in model performance, growing acceptance of algorithmic assistance among clinicians, and increasing emphasis on validation and governance to ensure patient safety and equitable outcomes. At the same time, policy shifts and trade dynamics are reshaping supply chain decisions, nudging stakeholders toward software-first architectures and diversified sourcing strategies.

Moving forward, successful adoption will hinge on multi-stakeholder collaboration: developers must prioritize clinical relevance and explainability, providers must commit to rigorous evaluation and clinician training, and payers must consider reimbursement models that reflect demonstrable clinical and operational improvements. By aligning technical design with regulatory expectations and operational realities, organizations can realize the potential of AI to enhance diagnostic accuracy, increase efficiency, and support more personalized care delivery. Ultimately, the path to sustained impact lies in marrying technological innovation with disciplined evidence generation and pragmatic deployment strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Medical Diagnostics Market, by Component

  • 8.1. Hardware
    • 8.1.1. Memory
    • 8.1.2. Processors
  • 8.2. Services
    • 8.2.1. Installation & Integration
  • 8.3. Software
    • 8.3.1. Diagnostic Software
    • 8.3.2. Imaging Software
    • 8.3.3. Predictive Analysis Software

9. Artificial Intelligence in Medical Diagnostics Market, by Technology Type

  • 9.1. Computer Vision
  • 9.2. Data Mining
  • 9.3. Deep Learning
  • 9.4. Machine Learning
  • 9.5. Natural Language Processing

10. Artificial Intelligence in Medical Diagnostics Market, by Deployment Mode

  • 10.1. Cloud-Based
  • 10.2. On-Premise

11. Artificial Intelligence in Medical Diagnostics Market, by Application

  • 11.1. Imaging and Diagnostics Application
    • 11.1.1. Cardiology
    • 11.1.2. Neurology
    • 11.1.3. Obstetrics/Gynecology
    • 11.1.4. Oncology
    • 11.1.5. Ophthalmology
    • 11.1.6. Radiology
  • 11.2. In-Vitro Diagnostics Application
    • 11.2.1. Companion Diagnostics
    • 11.2.2. Immunoassay Diagnostics
    • 11.2.3. Molecular Diagnostics
  • 11.3. Personalized Medicine
  • 11.4. Remote Monitoring & Telehealth

12. Artificial Intelligence in Medical Diagnostics Market, by End-User

  • 12.1. Academic Institutions
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals
  • 12.4. Research Laboratories

13. Artificial Intelligence in Medical Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Artificial Intelligence in Medical Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Artificial Intelligence in Medical Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Artificial Intelligence in Medical Diagnostics Market

17. China Artificial Intelligence in Medical Diagnostics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. AiCure, LLC
  • 18.7. Aidoc Medical Ltd.
  • 18.8. Butterfly Network, Inc.
  • 18.9. Cera Care Limited
  • 18.10. Cisco Systems, Inc.
  • 18.11. Corti - AI
  • 18.12. Digital Diagnostics Inc.
  • 18.13. Edifecs, Inc.
  • 18.14. Enlitic, Inc.
  • 18.15. Epredia by PHC Holdings Corporation
  • 18.16. Freenome Holdings, Inc.
  • 18.17. GE HealthCare Technologies, Inc.
  • 18.18. General Vision, Inc.
  • 18.19. Google LLC by Alphabet Inc.
  • 18.20. Hewlett Packard Enterprise Development LP
  • 18.21. Imagen Technologies, Inc.
  • 18.22. Intel Corporation
  • 18.23. International Business Machines Corporation
  • 18.24. Johnson & Johnson Services, Inc.
  • 18.25. Kantify
  • 18.26. Koninklijke Philips N.V.
  • 18.27. Medtronic PLC
  • 18.28. Microsoft Corporation
  • 18.29. Nano-X Imaging Ltd.
  • 18.30. NEC Corporation
  • 18.31. NVIDIA Corporation
  • 18.32. Persistent Systems Limited
  • 18.33. Qure.ai Technologies Private limited
  • 18.34. Siemens Healthineers AG
  • 18.35. SigTuple Technologies Private Limited
  • 18.36. Stryker Corporation
  • 18.37. Tempus Labs, Inc.
  • 18.38. VUNO Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 214. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 257.